Fed. Circ. Revives ImmunoGen's Cancer Treatment Patent App
The Federal Circuit ruled Friday that a Virginia federal court erred when it backed a U.S. Patent and Trademark Office finding that rejected ImmunoGen's application for a patent on a cancer treatment,...To view the full article, register now.
Already a subscriber? Click here to view full article